Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 976

1.

Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.

Saeidi M, Masoud A, Shakiba Y, Hadjati J, Mohyeddin Bonab M, Nicknam MH, Latifpour M, Nikbin B.

Iran J Allergy Asthma Immunol. 2013 Mar;12(1):37-49. doi: 012.01/ijaai.3749.

2.

Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells.

Wei X, Peng G, Zheng S, Wu X.

Cell Prolif. 2012 Apr;45(2):101-10. doi: 10.1111/j.1365-2184.2012.00809.x. Epub 2012 Feb 13.

PMID:
22324479
3.

Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.

Liu S, Yuan M, Hou K, Zhang L, Zheng X, Zhao B, Sui X, Xu W, Lu S, Guo Q.

Cell Immunol. 2012 Jul-Aug;278(1-2):35-44. doi: 10.1016/j.cellimm.2012.06.010. Epub 2012 Jul 16.

PMID:
23121974
4.

Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells.

Abomaray FM, Al Jumah MA, Kalionis B, AlAskar AS, Al Harthy S, Jawdat D, Al Khaldi A, Alkushi A, Knawy BA, Abumaree MH.

Stem Cell Rev. 2015 Jun;11(3):423-41. doi: 10.1007/s12015-014-9562-8.

PMID:
25287760
7.

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L.

Blood. 2009 Jun 25;113(26):6576-83. doi: 10.1182/blood-2009-02-203943. Epub 2009 Apr 27.

8.

Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.

Ivanova-Todorova E, Bochev I, Mourdjeva M, Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I, Kyurkchiev DS.

Immunol Lett. 2009 Sep 22;126(1-2):37-42. doi: 10.1016/j.imlet.2009.07.010. Epub 2009 Jul 30.

PMID:
19647021
9.

Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.

Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.

Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9.

10.

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB.

PLoS One. 2010 Feb 2;5(2):e9016. doi: 10.1371/journal.pone.0009016.

11.

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F.

Cell Immunol. 2011;272(1):33-8. doi: 10.1016/j.cellimm.2011.09.010. Epub 2011 Sep 29.

12.

Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.

He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A.

Tissue Eng Part A. 2014 Apr;20(7-8):1314-24. doi: 10.1089/ten.TEA.2013.0333. Epub 2014 Mar 14.

PMID:
24279891
13.

Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells.

van den Berk LC, Roelofs H, Huijs T, Siebers-Vermeulen KG, Raymakers RA, Kögler G, Figdor CG, Torensma R.

Immunology. 2009 Dec;128(4):564-72. doi: 10.1111/j.1365-2567.2009.03142.x.

14.

CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties.

Yang ZX, Han ZB, Ji YR, Wang YW, Liang L, Chi Y, Yang SG, Li LN, Luo WF, Li JP, Chen DD, Du WJ, Cao XC, Zhuo GS, Wang T, Han ZC.

PLoS One. 2013;8(3):e59354. doi: 10.1371/journal.pone.0059354. Epub 2013 Mar 12.

15.

Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.

Chen MY, Lie PC, Li ZL, Wei X.

Exp Hematol. 2009 May;37(5):629-40. doi: 10.1016/j.exphem.2009.02.003.

PMID:
19375653
16.

Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells.

Chen Y, Yang C, Jin N, Xie Z, Fei L, Jia Z, Wu Y.

Int Immunopharmacol. 2007 Aug;7(8):1102-10. Epub 2007 May 2.

PMID:
17570327
17.

Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.

Wu LF, Wang NN, Liu YS, Wei X.

Tissue Eng Part A. 2009 Oct;15(10):2865-73. doi: 10.1089/ten.TEA.2008.0579.

PMID:
19257811
18.
19.

Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.

Liu S, Hou KD, Yuan M, Peng J, Zhang L, Sui X, Zhao B, Xu W, Wang A, Lu S, Guo Q.

J Biosci Bioeng. 2014 Feb;117(2):229-35. doi: 10.1016/j.jbiosc.2013.07.001. Epub 2013 Jul 27.

PMID:
23899897
20.

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells.

Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N.

Blood. 2005 May 15;105(10):4120-6. Epub 2005 Feb 3.

Supplemental Content

Support Center